TCL1 Predicts Time to Treatment in Chronic Lymphocytic Leukemia

被引：0
|
作者：
Ng, D. P.
Bennett, R. R.
Lansigan, F.
Levy, N. B.
Danilov, A. V.
Kaur, P.
机构：
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1501
引用
收藏
页码：357A / 357A
页数：1
相关论文
共 50 条
  • [1] TCL1 Predicts Time to Treatment in Chronic Lymphocytic Leukemia
    Ng, D. P.
    Bennett, R. R.
    Lansigan, F.
    Levy, N. B.
    Danilov, A. V.
    Kaur, P.
    LABORATORY INVESTIGATION, 2012, 92 : 357A - 357A
  • [2] The TCL1 mouse as a model for chronic lymphocytic leukemia
    Hamblin, Terry J.
    LEUKEMIA RESEARCH, 2010, 34 (02) : 135 - 136
  • [3] Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
    Bichi, R
    Shinton, SA
    Martin, ES
    Koval, A
    Calin, GA
    Cesari, R
    Russo, G
    Hardy, RR
    Croce, CM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) : 6955 - 6960
  • [4] BAFF accelerates development of chronic lymphocytic leukemia in TCL1 transgenic mice
    Enzler, Thomas
    Widhopf, George F.
    Lee, Jason
    Zhang, Weizhou
    Croce, Carlo M.
    Karin, Michael
    Kipps, Thomas J.
    BLOOD, 2007, 110 (11) : 339A - 339A
  • [5] Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia
    Kater, Arnon P.
    Slinger, Erik
    Cretenet, Gaspard
    Martens, Anne W.
    Balasubramanian, Sriram
    Leverson, Joel D.
    Eldering, Eric
    BLOOD ADVANCES, 2021, 5 (23) : 5410 - 5414
  • [6] Combinatorial Treatment of Chronic Lymphocytic Leukemia with Ibrutinib and Venetoclax Is Superior to Treatment with Single Agents in the TCL1 Mouse Model
    Slinger, Erik
    Balasubramanian, Sriram
    Leverson, Joel D.
    Eldering, Eric
    Kater, Arnon P.
    BLOOD, 2017, 130
  • [7] Role of the splenic microenvironment in chronic lymphocytic leukemia development in Eμ-TCL1 transgenic mice
    Collard, James P.
    McKenna, Mary K.
    Noothi, Sunil K.
    Alhakeem, Sara S.
    Rivas, Jacqueline R.
    Rangnekar, Vivek M.
    Muthusamy, Natarajan
    Bondada, Subbarao
    LEUKEMIA & LYMPHOMA, 2022, 63 (08) : 1810 - 1822
  • [8] Marrow Stromal Cells Induce TCL1 Expression in Chronic Lymphocytic Leukemia B Cells
    Sivina, Mariela
    Hartmann, Elena
    Keating, Michael
    Wierda, William G.
    Rosenwald, Andreas
    Burger, Jan A.
    BLOOD, 2009, 114 (22) : 927 - 927
  • [9] PKCβ is essential for the development of chronic lymphocytic leukemia in the TCL1 transgenic mouse model: validation of PKCβ as a therapeutic target in chronic lymphocytic leukemia
    Holler, Claudia
    Pinon, Josefina D.
    Denk, Ursula
    Heyder, Christoph
    Hofbauer, Sebastian
    Greil, Richard
    Egle, Alexander
    BLOOD, 2009, 113 (12) : 2791 - 2794
  • [10] TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia
    Eva Szenes
    Andrea Härzschel
    Sarah Decker
    Erika Tissino
    Justine Pischeli
    Julia Christine Gutjahr
    Sandra Kissel
    Sandra Pennisi
    Jan Philip Höpner
    Alexander Egle
    Nadja Zaborsky
    Christine Dierks
    Marie Follo
    Alexandre Chigaev
    Antonella Zucchetto
    Richard Greil
    Valter Gattei
    Tanja Nicole Hartmann
    Leukemia, 2020, 34 : 2498 - 2502
12345